CIK 0001954488 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in E9
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-05-15 | 20-F | ANNUAL REPORT | 2025-12-31 |
| 2026-04-29 | NT 20-F | NOTIFICATION OF LATE FILING | 2025-12-31 |
| 2026-04-24 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-04-14 | 3 | PRIMARY DOCUMENT | 2026-04-13 |
| 2026-04-08 | 3 | PRIMARY DOCUMENT | 2026-04-08 |
| 2026-04-01 | 3 | PRIMARY DOCUMENT | 2026-04-01 |
| 2026-04-01 | 3 | PRIMARY DOCUMENT | 2026-04-01 |
| 2026-04-01 | 3 | PRIMARY DOCUMENT | 2026-04-01 |
| 2026-04-01 | 3 | PRIMARY DOCUMENT | 2026-04-01 |
| 2026-04-01 | 3 | PRIMARY DOCUMENT | 2026-04-01 |
| 2026-02-06 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-02-06 |
| 2026-01-09 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-09 |
| 2025-06-30 | SP 15D2 | SP 15D2 | 2024-12-31 |
| 2025-06-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-06-18 |
| 2025-06-18 | 424B4 | PROSPECTUS | |
| 2025-06-16 | EFFECT | EFFECT items ,, | |
| 2025-06-16 | CERT | CERT | |
| 2025-06-12 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | |
| 2025-06-12 | CORRESP | CORRESP | |
| 2025-06-12 | CORRESP | CORRESP | |
| 2025-06-06 | POS AM | REGISTRATION STATEMENT | |
| 2025-04-23 | POS AM | POST-EFFECTIVE AMENDMENT | |
| 2025-03-31 | EFFECT | EFFECT items ,, | |
| 2025-03-28 | CORRESP | CORRESP | |
| 2025-03-28 | CORRESP | CORRESP |
Forms on file (last 1,000): CORRESP 15, UPLOAD 13, F-1/A 12, 3 7, FWP 4, 6-K 3, EFFECT 2, POS AM 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MENS (0.002 USD), /gw/filings/filings?ticker=MENS&form=8-K, /gw/filings/facts?ticker=MENS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange